Page last updated: 2024-08-24

gemcitabine and Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

gemcitabine has been researched along with Precursor T-Cell Lymphoblastic Leukemia-Lymphoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bing, X; Haijun, Z; Lian, Y; Manman, D; Silei, B; Xiufeng, Z; Yong, Z; Zhihong, F	1

Other Studies

1 other study(ies) available for gemcitabine and Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Article	Year
Co-operation of ABT-199 and gemcitabine in impeding DNA damage repair and inducing cell apoptosis for synergistic therapy of T-cell acute lymphoblastic leukemia. Anti-cancer drugs, 2019, Volume: 30, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bridged Bicyclo Compounds, Heterocyclic; Case-Control Studies; Cell Proliferation; Deoxycytidine; DNA Damage; DNA Repair; Drug Synergism; Gemcitabine; Humans; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Sulfonamides; Tumor Cells, Cultured	2019

Article

Year

Co-operation of ABT-199 and gemcitabine in impeding DNA damage repair and inducing cell apoptosis for synergistic therapy of T-cell acute lymphoblastic leukemia.

Anti-cancer drugs, 2019, Volume: 30, Issue:2

Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bridged Bicyclo Compounds, Heterocyclic; Case-Control Studies; Cell Proliferation; Deoxycytidine; DNA Damage; DNA Repair; Drug Synergism; Gemcitabine; Humans; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Sulfonamides; Tumor Cells, Cultured

2019